Idioma:

Treatment of Urogenital Symptoms in Individuals With a History of Estrogen-dependent Breast Cancer: Clinical Consensus

Obstetrics and gynecology (New York. 1953), 2021-12, Vol.138 (6), p.950-960 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por

Enviar para

Título:
Treatment of Urogenital Symptoms in Individuals With a History of Estrogen-dependent Breast Cancer: Clinical Consensus
Assuntos: Breast Neoplasms - complications ; Breast Neoplasms - metabolism ; Cancer Survivors ; Consensus ; Estrogens - administration & dosage ; Estrogens - metabolism ; Female ; Female Urogenital Diseases - drug therapy ; Female Urogenital Diseases - etiology ; Female Urogenital Diseases - metabolism ; Gynecology - standards ; Hormone Replacement Therapy - standards ; Humans ; Menopause, Premature - metabolism ; Urology - standards
É parte de: Obstetrics and gynecology (New York. 1953), 2021-12, Vol.138 (6), p.950-960
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: With an estimated 3.8 million breast cancer survivors in the United States, obstetrician-gynecologists often are on the front lines of addressing survivorship issues, including the hypoestrogenic-related adverse effects of cancer therapies or early menopause in survivors (1). Although systemic and vaginal estrogen are used widely for symptomatic relief of genitourinary syndrome of menopause in the general population, among individuals with a history of hormone-sensitive cancer, there is uncertainty about the safety of hormone-based therapy, leading many individuals with bothersome symptoms to remain untreated, with potential negative consequences on quality of life (2). An effective management strategy requires familiarity with a range of both hormonal and nonhormonal treatment options, knowledge about the pharmaceutical mechanisms of action, and the ability to tailor treatment based on individual risk factors. This clinical consensus document was developed using an a priori protocol in conjunction with two authors specializing in urogynecology and gynecologic oncology. This document has been updated to review the safety and efficacy of newer hormonal treatment options as well as nonhormonal modalities.
Editor: United States
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Treatment of Urogenital Symptoms in Individuals With a History of Estrogen-dependent Breast Cancer: Clinical Consensus

United States

Buscando em bases de dados remotas. Favor aguardar.